Credit Suisse analyst Alonso Garcia downgrades Banco De Chile (NYSE:BCH) from Outperform to Neutral.
Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $88
Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $84 to $88.